Lannett Company Inc. (fka LCINQ)

[levelnever]

Ritonavir being used as part of current coronavirus treatment regimen in China. From discussion yesterday: http://news.cnhubei.com/content/2020-01/28/content_12656365.html

Wuhan Institute of Virology, Chinese Academy of Sciences and others have found that 3 drugs have a good inhibitory effect on new coronavirus

Release time: January 28, 2020 23:38 Source: Hubei Daily

Hubei Daily (Reporter Wen Jun, correspondent Long Hua, Hu Shuwei) On January 28, a series of good news came out from the Wuhan Institute of Virology, Chinese Academy of Sciences: The institute has just developed antibody test strips for research; The Institute and the Institute of Toxicology and Drugs of the Academy of Military Medical Sciences have jointly found Remdesivir or Remdesivir (GS-5734), chloroquine (Remdesivir (GS-5734), chloroquine ( Chloroquine, Sigma-C6628), Ritonavir and three other "old drugs". Its subsequent clinical use is undergoing related procedures for approval.

In the past few days, relevant departments and scientific research units of the scientific and technological circles in our province have stepped up scientific and technological research and development, highlighted the urgent need for prevention and control, gave full play to the role of experts, and endeavored to provide scientific and technological support for front-line prevention and control treatment. Ning Qin, chief physician of the Department of Infectious Diseases, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, pointed out that most patients with pneumonitis infected by new coronavirus have a good prognosis and a few patients are critically ill; symptoms of children are relatively mild, and the elderly and those with basic diseases are infected. Heavier. Based on current epidemiological investigations, the incubation period of the virus is 3-7 days, with a maximum of 14 days. She believes that in view of the similarities between the new coronavirus and SARS-Cov virus and their clinical symptoms, it is speculated that the pathogenic mechanism is likely to be caused by the activation of the body's autoimmune attack on autologous lungs and immune organs, but the specific mechanism uncertain.

On January 21, according to the urgent scientific and technological needs of rapid epidemic disposal and emergency response, the Provincial Department of Science and Technology launched the "2019 New Pneumonia Emergency Science and Technology Research Project", established a new type of pneumonia emergency scientific research research expert group, and quickly promoted related research work. The Scientific Research Group of the Pneumonia Prevention and Control Headquarters of Hubei Province New Coronavirus Infection organized a strong team in the province in several related fields such as virology and epidemiology, led by the Wuhan Institute of Virology of the Chinese Academy of Sciences, focusing on "rapid detection technology products" Emergency research has been initiated in five areas, including R & D, the law of disease occurrence, development, and outcome, and clinical diagnosis and treatment, antiviral emergency drugs and vaccines, animal traceability research, and etiology and epidemiology research. With a view to carrying out epidemiological investigation and etiology traceability as soon as possible, revealing the mechanisms and rules of inflammatory response caused by pathogen infection as soon as possible, providing the foundation for disease treatment and drug development as soon as possible, and forming the ability to quickly detect and respond to new-type coronavirus as soon as possible. At present, the Ministry of Science and Technology is organizing scientific and technological research on the diagnosis and treatment of new pneumonia. The emergency science and technology research project initiated by Hubei Province is very timely. The scientific research and research system on the diagnosis and treatment of new pneumonia has been formed with the emergency research on new pneumonia diagnosis and treatment carried out by the Ministry of Science and Technology.

Wu Tangchun, dean and professor of the School of Public Health of Tongji Medical College of Huazhong University of Science and Technology, believes that the highest priority and most effective prevention and control strategy is still to control the source of infection and cut off the transmission route. Monitoring and screening of hospitals and crowded places should be strengthened, medical institutions at all levels should be urged to report cases and suspected cases in a timely manner, strengthen the training of medical and health technicians, and improve the ability of early identification and diagnosis of cases. It is necessary to implement centralized centralized treatment of cases And suspected cases and treated in isolation. Considering the source of infection, the effectiveness of treatment, and the mortality rate, suggestions for encouraging mild and moderate suspected patients to be isolated and treated at home should be supported instead of waiting in line at the hospital.

Professor Tongchun Chun also believes that because the transmission of new coronavirus pneumonia is still not completely clear, drawing on the main prevention and control experience of respiratory infectious diseases, it is recommended to cut off the transmission through strengthening disinfection, ventilation, personal protection and other means, and to strengthen the tracking of close contacts, Detection, isolation and protection. The public must treat the epidemic rationally without panic.